Basel, 22 May 2020 – Roche (SIX: RO, ROG; OTCQX: RHHBY) today announced that it …
Read More »
INDIANAPOLIS, May 28, 2020 /PRNewswire/ — TAUVID™, a radioactive diagnostic agent, has been approved by the FDA for …
Read More »
BOULDER, Colo., May 26, 2020 /PRNewswire/ — ArcherDX, Inc., today announced a strategic collaboration with …
Read More »
Last year, 2016, brought a whirlwind of changes and progress to the hepatitis C field, …
Read More »
INDIANAPOLIS, May 28, 2020 /PRNewswire/ — TAUVID™, a radioactive diagnostic agent, has been approved by the FDA for …
Read More »
NEW YORK and TOKYO, May 29, 2020 /PRNewswire/ — Pfizer Inc. (NYSE: PFE) and Astellas Pharma …
Read More »
SAN DIEGO, May 28, 2020 /PRNewswire/ — Cardiff Oncology, Inc. (Nasdaq: CRDF), a clinical-stage oncology …
Read More »
OSAKA, Japan–(BUSINESS WIRE)–Takeda Pharmaceutical Company Limited (TOKYO:4502) (NYSE:TAK) (“Takeda”) today announces that on May 28, …
Read More »
CARMIEL, Israel, May 28, 2020 /PRNewswire/ — Protalix BioTherapeutics, Inc. (NYSE American: PLX) (TASE: PLX), …
Read More »
BASKING RIDGE, N.J. & MORRISVILLE, N.C.–(BUSINESS WIRE)–Daiichi Sankyo, Inc. (hereafter, Daiichi Sankyo) announced that it …
Read More »
NORTHBROOK, Ill., May 27, 2020 /PRNewswire/ — Astellas Pharma Inc. (TSE: 4503, President and CEO: …
Read More »
SHANGHAI and GAITHERSBURG, MD, May 27, 2020 /PRNewswire/ — I-Mab (NASDAQ: IMAB), a clinical-stage biopharmaceutical …
Read More »
BRANFORD, Conn.–(BUSINESS WIRE)–Azitra, Inc., a clinical-stage medical dermatology company addressing serious skin conditions by harnessing the …
Read More »
FOSTER CITY, Calif. & HAYWARD, Calif.–(BUSINESS WIRE)–Gilead Sciences, Inc. (NASDAQ: GILD) and Arcus Biosciences, Inc. …
Read More »
BOSTON–(BUSINESS WIRE)–Ironwood Pharmaceuticals, Inc. (NASDAQ: IRWD), a GI-focused healthcare company, today announced top-line data from a …
Read More »
FREDERICK, Md., May 27, 2020 /PRNewswire/ — Artesunate for Injection 110 mg, powder and solvent …
Read More »
SOUTH SAN FRANCISCO, Calif.–(BUSINESS WIRE)–Genentech, a member of the Roche Group (SIX: RO, ROG; OTCQX: …
Read More »
PRINCETON, N.J.–(BUSINESS WIRE)–Bristol Myers Squibb (NYSE: BMY) today announced that Opdivo (nivolumab) 360 mg plus Yervoy (ipilimumab) 1 mg/kg (injections …
Read More »
PARIS and TARRYTOWN, N.Y. – May 26, 2020 – The U.S. Food and Drug Administration (FDA) …
Read More »
Specialty Pharma Journal Specialty, Precision & Technology
